A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee
Public ClinicalTrials.gov record NCT02068599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (4% and 8% w/w Ointment) in Patients With Primary Osteoarthritis Affecting a Single Knee
Study identification
- NCT ID
- NCT02068599
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 389 participants
Conditions and interventions
Conditions
Interventions
- TV-45070 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2014
- Primary completion
- Apr 5, 2015
- Completion
- May 3, 2015
- Last update posted
- Nov 8, 2021
2014 – 2015
United States locations
- U.S. sites
- 42
- U.S. states
- 16
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 12217 | Anaheim | California | — | — |
| Teva Investigational Site 12244 | Anaheim | California | — | — |
| Teva Investigational Site 12252 | Cerritos | California | — | — |
| Teva Investigational Site 13009 | Cerritos | California | — | — |
| Teva Investigational Site 12233 | El Cajon | California | — | — |
| Teva Investigational Site 12240 | Lomita | California | — | — |
| Teva Investigational Site 12251 | Sacramento | California | — | — |
| Teva Investigational Site 12234 | Spring Valley | California | — | — |
| Teva Investigational Site 12256 | Clearwater | Florida | — | — |
| Teva Investigational Site 12241 | DeLand | Florida | — | — |
| Teva Investigational Site 12246 | Eustis | Florida | — | — |
| Teva Investigational Site 12231 | Fort Myers | Florida | — | — |
| Teva Investigational Site 12216 | Hialeah | Florida | — | — |
| Teva Investigational Site 12230 | Jacksonville | Florida | — | — |
| Teva Investigational Site 12220 | Miami | Florida | — | — |
| Teva Investigational Site 12221 | Oldsmar | Florida | — | — |
| Teva Investigational Site 12226 | Orlando | Florida | — | — |
| Teva Investigational Site 12237 | Orlando | Florida | — | — |
| Teva Investigational Site 12255 | Ormond Beach | Florida | — | — |
| Teva Investigational Site 12225 | Plantation | Florida | — | — |
| Teva Investigational Site 12229 | Sanford | Florida | — | — |
| Teva Investigational Site 12235 | Tampa | Florida | — | — |
| Teva Investigational Site 12253 | Atlanta | Georgia | — | — |
| Teva Investigational Site 12250 | Marietta | Georgia | — | — |
| Teva Investigational Site 12243 | Evansville | Indiana | — | — |
| Teva Investigational Site 12238 | Overland Park | Kansas | — | — |
| Teva Investigational Site 12218 | New Orleans | Louisiana | — | — |
| Teva Investigational Site 12245 | Watertown | Massachusetts | — | — |
| Teva Investigational Site 12228 | Bingham Farms | Michigan | — | — |
| Teva Investigational Site 12242 | Hazelwood | Missouri | — | — |
| Teva Investigational Site 12249 | St Louis | Missouri | — | — |
| Teva Investigational Site 12223 | Omaha | Nebraska | — | — |
| Teva Investigational Site 12219 | New York | New York | — | — |
| Teva Investigational Site 12239 | Charlotte | North Carolina | — | — |
| Teva Investigational Site 12248 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 12247 | Winston-Salem | North Carolina | — | — |
| Teva Investigational Site 12254 | Winston-Salem | North Carolina | — | — |
| Teva Investigational Site 12224 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12236 | Memphis | Tennessee | — | — |
| Teva Investigational Site 12232 | Dallas | Texas | — | — |
| Teva Investigational Site 12227 | Plano | Texas | — | — |
| Teva Investigational Site 12222 | Charlottesville | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02068599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02068599 live on ClinicalTrials.gov.